chrX-71223930-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000166.6(GJB1):c.223C>T(p.Arg75Trp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.223C>T | p.Arg75Trp | missense_variant | Exon 2 of 2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.223C>T | p.Arg75Trp | missense_variant | Exon 2 of 2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.223C>T | p.Arg75Trp | missense_variant | Exon 2 of 2 | XP_011529209.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1092506Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 358516
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This variant has been identified in multiple unrelated individuals with clinical features associated with this gene. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). Assessment of experimental evidence suggests this variant results in abnormal protein function. Studies showed defective protein activity and transgenic mice with a demyelinating neuropathy (PMID: 12460545, 19369543, 23209285, 28334782). -
Published functional studies demonstrate a damaging effect on the gene product (PMID: 12460545, 23209285); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Different missense changes at this residue (R75Q) and (R75P) have been reported in the Human Gene Mutation Database and in published literature (PMID: 8829637, 9272161, 23209285, 12460545, 32489946, 32399692; HGMD); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19369543, 9361298, 14663027, 12460545, 12402337, 17100997, 23209285, 30373780, 29095325, 32941234, 32399692, 9272161, 10732813, 8829637, 32489946) -
- -
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:2Other:1
- -
The GJB1 c.223C>T; p.Arg75Trp variant (rs116840819) is reported frequently in the literature in individuals affected with X-linked Charcot-Marie-Tooth neuropathy (select references: Silander 1997, Zhang 2005, Parissis 2017, and Bacquet 2018). Functional analyses of the variant protein in cell culture and transgenic mice show that the p.Arg75Trp variant causes defects in GJB1 protein function consistent with known CMT disease mechanisms (Sargiannidou 2009, Abrams 2013). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. Based on available information, this variant is considered to be pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
The p.R75W variant (also known as c.223C>T), located in coding exon 1 of the GJB1 gene, results from a C to T substitution at nucleotide position 223. The arginine at codon 75 is replaced by tryptophan, an amino acid with dissimilar properties. This variant has been detected in the hemizygous state in multiple unrelated males with Charcot-Marie-Tooth neuropathy X type 1 (CMTX1), as well as in heterozygous carrier females with mild symptoms (Vogt B et al. J Neurol, 2020 Sep;267:2648-2654; Silander K et al. Hum Genet, 1997 Sep;100:391-7; Zhang RX et al. Beijing Da Xue Xue Bao Yi Xue Ban, 2005 Feb;37:68-71; Parissis D et al. Neurologist, 2017 Nov;22:234-236). Functional studies indicate this alteration impairs gap junction formation and transgenic mice expressing this alteration recapitulate the phenotype (Kagiava A et al. Hum Mol Genet, 2018 04;27:1460-1473; Kyriakoudi S et al. Hum Mol Genet, 2017 05;26:1622-1633; Abrams CK et al. J Biol Chem, 2013 Feb;288:3609-19; Sargiannidou I et al. J Neurosci, 2009 Apr;29:4736-49). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 75 of the GJB1 protein (p.Arg75Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Charcot-Marie-Tooth disease (CMT) (PMID: 9272161, 10732813, 12402337, 14663027, 15719046, 17100997). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 21082). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GJB1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GJB1 function (PMID: 12460545, 19369543, 23209285). For these reasons, this variant has been classified as Pathogenic. -
Charcot-Marie-Tooth disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at